Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Vitreoretinal Associates, P.A.

Neither a doctor nor a teaching hospital

Research payments

$6,361

3 payments

Through program year 2024, Vitreoretinal Associates, P.A. is reported as receiving $6,361 in research payments, across 3 payments.

By program year

2 rows
Year Kind Amount Payments
2024 Research $1,570 1
2023 Research $4,791 2

Breakdown

Who paid Research payments · program years 2023–2024
  1. Astellas Pharma Global Development $6,361 3 payments
Studies the money was for Research payments · program years 2023–2024
  1. A Phase 3 Multicenter, Randomized, Double Masked, Sham-Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients with Geographic Atropy Secondary to Age-Related Macular Degeneration $6,361 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record